Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: A novel palliation technique

118Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives. Radiofrequency ablation (RFA) has replaced photodynamic therapy for premalignant and malignant lesions of the esophagus. However, there is limited experience in the bile duct. The objective of this pilot study was to assess the safety and efficacy of RFA in malignant biliary strictures. Methods: Twenty patients with unresectable malignant biliary strictures underwent RFA with stenting between June 2010 and July 2012. Diameters of the stricture before and after RFA, immediate and 30 day complications and stent patency were recorded prospectively. Results. A total of 25 strictures were treated. Mean stricture length treated was 15.2 mm (SD = 8.7 mm, Range = 3.5-33 mm). Mean stricture diameter before RFA was 1.7 mm (SD = 0.9 mm, Range = 0.5-3.4 mm) while the mean diameter after RFA was 5.2 mm (SD = 2 mm, Range = 2.6-9 mm). There was a significant increase of 3.5 mm (t = 10.8, DF = 24, P value =

Cite

CITATION STYLE

APA

Figueroa-Barojas, P., Bakhru, M. R., Habib, N. A., Ellen, K., Millman, J., Jamal-Kabani, A., … Kahaleh, M. (2013). Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: A novel palliation technique. Journal of Oncology. https://doi.org/10.1155/2013/910897

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free